Skip to main content
Filing year 2024

ORTHOPEDIC SURGERY SEMINARS INC

Salt Lake Cty, Utah·EIN 87-0517007·NTEE G9DZ · Diseases, Disorders & Medical Disciplines·501(c)(3)
Total revenue
$142k
Total assets
$1.8M
Total expenses
$20k
Reported officers
4

Reported officers (all unpaid)

No paid executives reported in 2024. ORTHOPEDIC SURGERY SEMINARS INC reported 4 unpaid officers and board members on its 990-PF.

Pres
Vice Pres
Sec Tres
Director
Financial trend

Revenue and expenses over time

ORTHOPEDIC SURGERY SEMINARS INC reported revenue and expenses across 3 filing years.

RevenueExpenses
$15k
$3k
2021
$186k
$21k
2023
$142k
$20k
2024
Total revenue and total expenses from IRS Form 990 filings.

This is a private foundation. Peers are foundations of similar asset size ($1M - $10M), because foundation pay scales with assets under management, not revenue.

Sector benchmark

What Diseases, Disorders & Medical Disciplines executives earn

ORTHOPEDIC SURGERY SEMINARS INC reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization nationwide earns a median of $91,250.

25th percentile
$43k
Median
$91,250
75th percentile
$169k
90th percentile
$325k

These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 2,397 organizations across 2,397 filings (2021 – 2024).

See full Diseases, Disorders & Medical Disciplines compensation data →
FAQ

Common questions about ORTHOPEDIC SURGERY SEMINARS INC

What are ORTHOPEDIC SURGERY SEMINARS INC's revenue and expenses?

In 2024, ORTHOPEDIC SURGERY SEMINARS INC reported $142k in total revenue and $20k in total expenses on its IRS Form 990.

Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.

This is a private foundation. Peers are foundations of similar asset size ($1M - $10M), because foundation pay scales with assets under management, not revenue.